Science and Technology for UPSC-August 2, 2023
- What are the names of the seven satellites launched by India into orbit? Answer: DS-SAR, VELOX-AM, ARCADE, SCOOB-II, NuLIoN, Galassia-2, ORB-12 STRIDER
- How many foreign satellites has ISRO orbited since 1999? Answer: 431
- What is the name of the Indian rocket used for this successful launch? Answer: PSLV Core Alone variant (PSLV-C56)
- Who is the Chairman of ISRO? Answer: S. Somanath
- What is the primary purpose of the DS-SAR satellite? Answer: Radar imaging
- What is the lift-off mass of the PSLV-C56 rocket? Answer: 228.6 tons
- From which launch pad did the rocket take off? Answer: First launch pad at Satish Dhawan Space Centre (SDSC)
- What is the final stage of the rocket mission that will address the space debris issue? Answer: Bringing it down to 300 km
- How long will the process of bringing the rocket down to 300 km take? Answer: About 1.30 hours
- When is the next rocket mission scheduled after this one? Answer: In August or early September.
- How many small satellites were launched as piggybacks with the primary satellite? Answer: Six
- Which university in Singapore launched the SCOOB-II satellite? Answer: Nanyang Technological University
- Which satellite belongs to NuSpace Pte Ltd, Singapore? Answer: NuLIoN
- What is the mass of the Galassia-2 satellite? Answer: 3.5 kg
- Who owns the ORB-12 STRIDER satellite? Answer: Aliena Pte. Ltd., Singapore.
Science and Technology for UPSC-Dec 11, 2022
1-Covaxin was created by Bharat Biotech and the Indian Council of Medical Research (ICMR). The new coronavirus needed to create Covaxin had been isolated by ICMR’s National Institute of Virology (NIV). The development of the vaccine was partially supported by the Indian government.
2-The WHO stopped providing Covaxin to UN entities in April due to violations of good manufacturing practises. The only Covid-19 vaccine that was suspended by the WHO was Covaxin.
3-Bharat Biotech International Ltd (BBIL), based in Hyderabad, India’s Genome Valley, has developed world-class vaccination and biotherapeutics, research and product development, Bio-Safety Level 3 manufacturing, as well as vaccine supply and distribution.
Science and Technology for UPSC
4-Two months before to the release of Phase 3 results, the Central Drugs Standard Control Organization (CDSCO) granted Covaxin an Emergency Use Authorization (EUA). A controversy erupted over the approval’s “clinical trial mode” and lack of interim efficacy evidence.
5-Due to BBIL’s dedication to international social innovation programmes and the public-private collaboration, ground-breaking WHO pre-qualified vaccinations against polio, rotavirus, and typhoid illnesses, such as Biopolio, Rotavac, Rotavac 5D, and Typbar TCV, were introduced.
6-A student evacuated from Wuhan, China, was the first documented case of Covid infection in India on January 30, 2020, and the first fatality was reported on March 12, 2020.
Science and Technology for UPSC
7-On January 2, 2021, emergency use authorization was obtained for the Covishield and Covaxin vaccines, both of which were made in India. On January 16, the nationwide immunisation campaign was officially launched, with front-line healthcare personnel receiving vaccinations first. On February 19, India reached the milestone of one billion immunizations.
8-A vaccination drive for people over 60 and those with co-morbidities in the 45–60 age range started on March 1, 2021. Beginning on April 1, everyone over the age of 45 became eligible for the Covid immunisation. On May 1, all people (18+) became qualified to receive the Covid vaccine.
9-On June 25 of last year, India gave the first 25 billion vaccination doses, and on October 21, 2021, it reached the 100 billion vaccine mark. Later, the government started the Har Ghar Dastak immunisation drive with the goal of having everyone receive their first dose by November 3, 2021.
Science and Technology for UPSC
10-On January 3, 2022, the vaccination campaign for adolescents (15–18) got underway. Starting on January 10 of this year, frontline workers and vulnerable adults over 60 started receiving prophylactic doses.
11-As of right now, India has given out 2,19,96,78,118 (219.96 crore) vaccines in total, including 1,02,70,86,712 (102 crore) first doses, 95,09,07,151 (95.09 crore) second doses, and 22,16,84,255 (22.15 crore) precaution doses.
For GK and current affairs, click here
For current affairs, click here
For video news of India and the world, click here